HighTower Advisors
GMAB icon

HighTower Advisors’s Genmab GMAB Stock Holding History

HighTower Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,433
Closed -$414K – 3900
2026
Q1 		$414K Buy
+15,433
New +$462K ﹤0.01% 2890
2024
Q4 		– Sell
-11,384
Closed -$273K – 3913
2024
Q3 		$273K Buy
+11,384
New +$304K ﹤0.01% 2881
2024
Q2 		– Sell
-7,682
Closed -$224K – 3781
2024
Q1 		$224K Sell
7,682
-7,336
-49% -$216K ﹤0.01% 2920
2023
Q4 		$477K Buy
15,018
+6,009
+67% +$189K ﹤0.01% 2357
2023
Q3 		$322K Buy
9,009
+2,114
+31% +$80.6K ﹤0.01% 2543
2023
Q2 		$263K Buy
+6,895
New +$275K ﹤0.01% 2652
2023
Q1 		– Sell
-6,084
Closed -$256K – 3523
2022
Q4 		$256K Buy
+6,084
New +$251K ﹤0.01% 2591
2020
Q4 		– Sell
-6,370
Closed -$228K – 2703
2020
Q3 		$228K Sell
6,370
-19,211
-75% -$695K ﹤0.01% 2008
2020
Q2 		$870K Buy
+25,581
New +$697K ﹤0.01% 1192

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

HighTower Advisors's GMAB Position: Q2 2026 in Review

HighTower Advisors sold out of Genmab (GMAB) in Q2 2026, closing a stake of 15,433 shares — an estimated $414K sold.

HighTower Advisors first reported a position in GMAB in Q2 2020 and held it in 9 quarters. The position peaked at $870K in Q2 2020. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • HighTower Advisors reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • HighTower Advisors sold 15,433 Genmab shares in Q2 2026, an estimated $414K.
  • HighTower Advisors first reported a position in Genmab in Q2 2020 and held it in 9 quarters.
  • HighTower Advisors's Genmab position peaked at $870K in Q2 2020.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.